CHronic use of Amiodarone aGAinSt Implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy Study: Rationale and design of a randomized clinical trial

Autor: Martinelli, Martino, Rassi, Anis, Antonio Marin-Neto, Jose, Paola, Angelo Amato Vincenzo de [UNIFESP], Berwanger, Otavio, Scanavacca, Mauricio Ibraim, Kalil, Roberto, Siqueira, Sergio Freitas de, CHAGASICS Investigators

Publikováno v: Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP

St Jude Background the implantable cardioverter defibrillator (ICD) is better than antiarrhythmic drug therapy for the primary and secondary prevention of all-cause mortality and sudden cardiac death in patients with either coronary artery disease or

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14214e8949519d78c5f7808a8d5b1860
http://repositorio.unifesp.br/handle/11600/36994